Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Alfimeprase: Phase II restarted

NUVO restarted the open-label, single-arm, international SONOMA-3 trial in up to 100 patients with venous catheter occlusion. NUVO said the trial is

Read the full 224 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE